Atlas Venture Associates Opportunity I, LLC

CIK 1780066 · last filed 2024-03-05

Atlas Venture Associates Opportunity I, LLC is a corporate insider who has filed 8 SEC Form 4 insider transactions across 4 companies since 2021. The most recent filing shows the insider sold $1.4M of DYN on Mar 5, 2024. Across all open-market trades the lifetime net is −$18.9M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $753.1M across reported positions. The firm reports its address in Cambridge, MA. 45 SEC filings were submitted jointly with Atlas Venture Opportunity Fund I, L.P.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure
$753.11M
Companies
4
Total Filings
8
Lifetime Open-Market Net
-$18.95M

Charts

Trading activity, where the exposure sits, and each trade against the stock price.

DYN price and trades

Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.

Shares held

Shares owned after each reported transaction on this company (direct holdings as reported).

Open-market buying and selling

by month

Dollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.

Exposure by company

latest
OfficerDirector10% owner* stale (no filing in 3 yrs)

Most recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.

Filer Profile

Reported Address
400 TECHNOLOGY SQUARE
10TH FLOOR
CAMBRIDGE, MA 02139
Phone
(857) 201-2700
State of Incorporation
DE
Related Filers
Atlas Venture Opportunity Fund I, L.P. — 45 joint filings, latest 2026-02-09
Atlas Venture Associates Opportunity I, L.P. — 43 joint filings, latest 2026-02-09
ATLAS VENTURE ASSOCIATES X, L.P. — 24 joint filings, latest 2026-02-09
Atlas Venture Associates X, LLC — 24 joint filings, latest 2026-02-09
Atlas Venture Fund X, L.P. — 19 joint filings, latest 2026-02-09
Atlas Venture Fund XI, L.P. — 18 joint filings, latest 2024-02-28
Atlas Venture Associates XI, L.P. — 17 joint filings, latest 2024-02-28
Atlas Venture Associates XI, LLC — 17 joint filings, latest 2024-02-28
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count in each company: direct shares plus every indirect holder (trusts, LLCs, partnerships, family members) on the latest Form 4 that lists them. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
DYN 10%+ Owner 2,306,079 $16.04 $36.99M -$21.03M 2 2024-03-05
KYMR 10%+ Owner 5,984,736 $119.66 $716.12M -$11.99M 1 2022-12-16
Day One Biopharmaceuticals, Inc. (DAWN) Delisted 10%+ Owner 7,976,909 $21.53 $171.74M $19.50M 2 2022-06-22
Generation Bio Co. (GBIO) Delisted 10%+ Owner 61 $5.34 $326 -$5.44M 2 2021-06-28

Holdings By Holder

Who holds the shares on record: the insider directly, and each trust, LLC, partnership or family member reported as an indirect holder on the latest Form 4 that lists them. Holder names come from the filing's footnotes. Rows under No longer reported appeared on earlier filings but not the latest one, usually because the holder was emptied or folded into another; they are not counted in the total.
Symbol Holder Shares Share of Total Reported
DYN Direct 1,458,691 63.3% 2024-03-05
Atlas Venture Opportunity Fund II, L.P.
See footnote
847,388 36.7% 2024-03-05
Total 2,306,079
KYMR Direct 5,066,925 84.7% 2022-12-16
Atlas Venture Opportunity Fund I, L.P.
See footnote
917,811 15.3% 2022-12-16
Total 5,984,736
DAWN Direct 766,667 9.6% 2022-06-22
Atlas Venture Opportunity Fund I, L.P.
See footnote
7,210,242 90.4% 2022-06-22
Total 7,976,909
GBIO Direct 0 0.0% 2021-06-28
Atlas Venture Associates Opportunity I, LP
See footnote
61 100.0% 2021-06-28
Total 61

Recent Filings

8 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144, so not all of them end in a sale. Under each notice: the role the filer ticked on it, and whether a sale followed (a Form 4 sale within 30 days, or a sale listed on a later notice).
Filed Symbol Action Net Shares Net $ Link
2024-03-05 DYN Sell (S)10b5-1
Plan adopted Jan 10, 2024
−46,534 -$1.40M EDGAR
2024-02-28 DYN Sell (S)10b5-1
Plan adopted Jan 10, 2024
−807,838 -$19.63M EDGAR
2023-01-03 — Other (J) +2,718,023 $0
2022-12-16 KYMR Sell (S) −382,244 -$11.99M EDGAR
2022-06-22 Day One Biopharmaceuticals, Inc. (DAWN) Delisted Buy (P) +766,667 $11.50M EDGAR
2021-06-28 Generation Bio Co. (GBIO) Delisted Sell (S) −31,008 -$801.6K EDGAR
2021-06-23 Generation Bio Co. (GBIO) Delisted Sell (S) −185,078 -$4.64M EDGAR
2021-06-02 Day One Biopharmaceuticals, Inc. (DAWN) Delisted Mixed +9,002,776 $8.00M EDGAR
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
10b5-1: the filer ticked the box for trades made under a Rule 10b5-1 trading plan, which sets the sales (or buys) in advance, so they say less about the insider's view at the time than a discretionary trade. The plan's adoption date is shown when the filing's footnotes give it.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment, and an amended or cancelled notice is not listed. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes. Someone who is no longer an officer or director (or never was) files no Form 4, so for them a sale shows up only on a later notice, which lists the seller's sales from the 3 months before it. "No sale on file" means neither record shows one; a dash in Net $ means the value filed on the notice doesn't fit the stock's price (likely a typo).